drugset / Trial / NCT04423380
A Study to Investigate Safety and Tolerability of SH3051 Capsule in Patients With Advanced Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
The primary objective is to determine the safety profile of SH3051 in subjects with advanced solid tumors. The second objective is to evaluate the PK profile and preliminary efficacy of SH3051 solid tumors.
Timeline
- Start
- 2020-05-14
- Primary completion
- 2021-03
- Completion
- 2021-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SH3051 | Small molecule | 20 mg | Oral |
| Subject | SH3051 | Small molecule | 40 mg | Oral |
| Subject | SH3051 | Small molecule | 60 mg | Oral |
| Subject | SH3051 | Small molecule | 80 mg | Oral |
| Subject | SH3051 | Small molecule | 100 mg | Oral |